Mannatech Presents Glyconutrient Science at the 10th Jenner Glycobiology and Medicine Symposium. Mechanisms That Might Contribute to the Cognitive Benefits of Mannatech’s Ambrotose® Polysaccharides Are Presented.
Mannatech recently presented product research at the prestigious 10th Jenner Glycobiology and Medicine Symposium, which was held in The Hague, the Netherlands, March 31-April 3, 2012. The pre-clinical study showed that intake of Advanced Ambrotose® powder had positive effects in the brain on the expression of genes associated with the regulation of learning, memory and mood (1)*. These preliminary findings are compatible with multiple controlled human clinical studies which indicate that intake of Ambrotose products provides significant cognitive benefits to healthy adults.*
The study was authored by Dr. Erika N. Nelson, Jane Ramberg and Dr. Robert Sinnott. Dr. Nelson earned her BS in Genetics from the University of Kansas in Lawrence and went on to obtain her PhD in Neuroscience at the University of Texas Southwestern Medical Center in Dallas. She has published a number of papers on neurodevelopmental disorders and brain epigenetics. A candidate for a Masters of Business Administration at the University of Texas at Dallas, Dr. Nelson is also a consultant for Mannatech. Dr. Sinnott is CEO and CSO at Mannatech and Jane Ramberg is Director of Product Substantiation at Mannatech.
The 10th Jenner Glycobiology and Medicine Symposium brings together scientists from around the world, including many thought leaders in the field of glycobiology. The United Kingdom’s Royal Society of Medicine has been hosting these meetings—devoted to providing a forum for scientists and clinicians to disseminate the findings of current leading edge research in both novel and classic fields of glycobiology—for over 20 years. More information about the meeting can be found here: http://www.rsm.ac.uk/jenner10/.Press Releases